WALTHAM, Mass., August 12, 2025--BostonGene, a leader in AI-powered solutions for drug discovery and development, today announced the publication of a pivotal study, "Clinical and analytical ...

Identifying Patients With Low Relapse Rate Despite High-Risk Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Early Breast Cancer: Development and Validation of a ...